Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Chronic Heart Failure

Free Subscription Articles published in J Cardiol Retrieve available abstracts of 118 articles: HTML format

Single Articles

November 2023
1. HEIDENREICH P
   Heart failure management guidelines: New recommendations and implementation.
   J Cardiol. 2023 Nov 8:S0914-5087(23)00271-X. doi: 10.1016/j.jjcc.2023.
   PubMed     Abstract available
   
   
   October 2023
2. UCHIYAMA S, Toki M, Kitai T, Yoshioka K, et al
   Dynamic changes in echocardiographic parameters in acute decompensated heart failure: REALITY-ECHO.
   J Cardiol. 2023 Oct 24:S0914-5087(23)00268-X. doi: 10.1016/j.jjcc.2023.
   PubMed     Abstract available
   
   
   
3. POL T, Karlstrom P, Lund LH
   Heart failure registries - Future directions.
   J Cardiol. 2023 Oct 14:S0914-5087(23)00257-5. doi: 10.1016/j.jjcc.2023.
   PubMed     Abstract available
   
   
   
4. SI J, Ding Z, Hu Y, Zhang X, et al
   Predictors and prognostic implications of left ventricular ejection fraction trajectory improvement in the spectrum of heart failure with reduced and mildly reduced ejection fraction.
   J Cardiol. 2023 Oct 5:S0914-5087(23)00242-3. doi: 10.1016/j.jjcc.2023.
   PubMed     Abstract available
   
   
   
5. OKAMURA M, Kataoka Y, Taito S, Fujiwara T, et al
   Early mobilization for acute heart failure: A scoping and a systematic review.
   J Cardiol. 2023 Oct 3:S0914-5087(23)00239-3. doi: 10.1016/j.jjcc.2023.
   PubMed     Abstract available
   
   
   September 2023
6. SEO M, Watanabe T, Yamada T, Morita T, et al
   The clinical relevance of mild cognitive impairment in acute heart failure: A comparison with cognitive impairment.
   J Cardiol. 2023 Sep 6:S0914-5087(23)00222-8. doi: 10.1016/j.jjcc.2023.
   PubMed     Abstract available
   
   
   
7. MATSUDA H, Kuragaichi T, Sato Y
   Investigating the seasonal variation of heart failure hospitalizations and in-hospital mortality risks in Japan using a nationwide database.
   J Cardiol. 2023 Sep 2:S0914-5087(23)00219-8. doi: 10.1016/j.jjcc.2023.
   PubMed     Abstract available
   
   
   August 2023
8. HORIBE H, Ando K, Maekawa Y, Narisawa M, et al
   The association of serum adiponectin level with activities of daily living in hospitalized elderly patients with heart failure.
   J Cardiol. 2023 Aug 15:S0914-5087(23)00202-2. doi: 10.1016/j.jjcc.2023.
   PubMed     Abstract available
   
   
   
9. HARRISON NE, Ehrman R, Collins S, Desai AA, et al
   The prognostic value of improving congestion on lung ultrasound during treatment for acute heart failure differs based on patient characteristics at admission.
   J Cardiol. 2023 Aug 12:S0914-5087(23)00190-9. doi: 10.1016/j.jjcc.2023.
   PubMed     Abstract available
   
   
   
10. ICHIHARA YK, Kohsaka S, Kisanuki M, Sandhu ATS, et al
    Implementation of evidence-based heart failure management: Regional variations between Japan and the USA.
    J Cardiol. 2023 Aug 3:S0914-5087(23)00185-5. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
11. KLARSKOV VR, Ladefoged BT, Pedersen ALD, Hartig-Andreasen C, et al
    Clinical characteristics and prognostic implications of orthopedic ligament disorders in patients with wild-type transthyretin amyloidosis cardiomyopathy.
    J Cardiol. 2023;82:122-127.
    PubMed     Abstract available
    
    
    July 2023
12. YUASA N, Obokata M, Harada T, Kagami K, et al
    Characterization and Prognostic Importance of Chronotropic Incompetence in Heart Failure with Preserved Ejection Fraction.
    J Cardiol. 2023 Jul 5:S0914-5087(23)00159-4. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
13. FERREIRA JP, Zannad F, Kiernan MS, Konstam MA, et al
    High- versus low-dose losartan and uric acid: An analysis from HEAAL.
    J Cardiol. 2023;82:57-61.
    PubMed     Abstract available
    
    
    
14. UGATA Y, Hayashi T, Yamamoto S, Fujita H, et al
    Impact of Q wave in synthesized V7-9 lead on long-term outcomes after cardiac resynchronization therapy.
    J Cardiol. 2023;82:51-56.
    PubMed     Abstract available
    
    
    
15. MATSUURA K, Kumamaru H, Kohsaka S, Kanda T, et al
    Impact of concomitant mitral regurgitation during transcatheter aortic valve replacement on 1-year survival outcomes.
    J Cardiol. 2023;82:16-21.
    PubMed     Abstract available
    
    
    
16. NAKAGAWA S, Takahama H, Hoshino K, Yanagi Y, et al
    Prevalence and predictive factors for clinical outcomes of isolated functional tricuspid regurgitation.
    J Cardiol. 2023;82:8-15.
    PubMed     Abstract available
    
    
    June 2023
17. BHATIA K, Sabharwal B, Gupta K, Lopez PD, et al
    Clinical outcomes of intravenous Iron therapy in patients with heart failure and Iron deficiency: Meta-analysis and trial sequential analysis of randomized clinical trials.
    J Cardiol. 2023 Jun 26:S0914-5087(23)00157-0. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
18. GUDENKAUF B, Shaya G, Mukherjee M, Michos ED, et al
    Insulin resistance is associated with subclinical myocardial dysfunction and reduced functional capacity in heart failure with preserved ejection fraction.
    J Cardiol. 2023 Jun 24:S0914-5087(23)00153-3. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
19. HUANG HT, Ko SL, Wang CY, Lo HC, et al
    Risk stratification for worsening renal function and renal decline in heart failure patients with reduced ejection fraction after sacubitril/valsartan treatment.
    J Cardiol. 2023 Jun 7:S0914-5087(23)00129-6. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    May 2023
20. NOGI K, Yamamoto R, Ueda T, Nogi M, et al
    Derivation and validation of a clinical predictive model of NT-proBNP >/=125 pg/mL to detect pre-heart failure.
    J Cardiol. 2023 May 27:S0914-5087(23)00126-0. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
21. KATAOKA N, Imamura T
    Prognostic impact of xanthine oxidoreductase activity in patients with heart failure and atrial fibrillation.
    J Cardiol. 2023 May 24:S0914-5087(23)00115-6. doi: 10.1016/j.jjcc.2023.
    PubMed    
    
    
    
22. TOGASHI I, Sato T
    Conduction system pacing: Current status and prospects.
    J Cardiol. 2023;81:413-419.
    PubMed     Abstract available
    
    
    
23. SHIBASAKI I, Otani N, Saito S, Ogawa H, et al
    Overview of mechanical circulatory support for the management of post-myocardial infarction ventricular septal rupture.
    J Cardiol. 2023;81:491-497.
    PubMed     Abstract available
    
    
    April 2023
24. TAMAKI Y, Iwano H, Murayama M, Ishizaka S, et al
    Application of an echocardiographic scoring system of left ventricular filling pressure to diagnose acute heart failure in patients complaining dyspnea.
    J Cardiol. 2023 Apr 28:S0914-5087(23)00100-4. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
25. SEGEV A, Maor E, Goldenfeld M, Itelman E, et al
    Atrial fibrillation in young hospitalized patients: clinical characteristics, predictors of new onset, and outcomes.
    J Cardiol. 2023 Apr 26:S0914-5087(23)00096-5. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
26. JOKI Y, Konishi H, Takasu K, Minamino T, et al
    Tofogliflozin, a sodium-glucose cotransporter 2 inhibitor, improves pulmonary vascular remodeling due to left heart disease in mice.
    J Cardiol. 2023;81:347-355.
    PubMed     Abstract available
    
    
    
27. SHINKAWA T, Ichihara Y, Saito S, Ishido M, et al
    Ventricular assist device for end-stage adult congenital heart disease patients: Current status.
    J Cardiol. 2023;81:378-384.
    PubMed     Abstract available
    
    
    March 2023
28. KINOSHITA M, Saito M, Inoue K, Nakagawa H, et al
    Role of the right ventricular contractile reserve during low-load exercise in predicting heart failure readmission.
    J Cardiol. 2023 Mar 8:S0914-5087(23)00049-7. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
29. IMAMURA T, Narang N, Kinugawa K
    Clinical implications of remote dielectric sensing system to estimate lung fluid levels.
    J Cardiol. 2023;81:276-282.
    PubMed     Abstract available
    
    
    February 2023
30. MISUMI K, Matsue Y, Nogi K, Fujimoto Y, et al
    Derivation and validation of a machine learning-based risk prediction model in patients with acute heart failure.
    J Cardiol. 2023 Feb 27:S0914-5087(23)00045-X. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
31. TSUTSUI H, Sakamaki H, Momomura SI, Sakata Y, et al
    Cost-effectiveness analysis of Empagliflozin in patients with heart failure with reduced ejection fraction in Japan based on the EMPEROR-reduced trial.
    J Cardiol. 2023 Feb 27:S0914-5087(23)00046-1. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
32. WATANABE K, Arimoto T, Watanabe T, Otaki Y, et al
    Prognostic impact of plasma xanthine oxidoreductase activity in patients with heart failure with atrial fibrillation.
    J Cardiol. 2023 Feb 21:S0914-5087(23)00042-4. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
33. LI M, Ma W, Fan F, Yi T, et al
    Renal denervation in management of heart failure with reduced ejection fraction: A systematic review and meta-analysis.
    J Cardiol. 2023 Feb 7:S0914-5087(23)00021-7. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    December 2022
34. KINUGAWA K, Matsukawa M, Nakamura Y, Aihara M, et al
    Impact of tolvaptan add-on treatment on patients with heart failure requiring long-term congestion management: A retrospective cohort study using a medical claim database in Japan.
    J Cardiol. 2022 Dec 29:S0914-5087(22)00323-9. doi: 10.1016/j.jjcc.2022.
    PubMed     Abstract available
    
    
    
35. SHIMOMOTO R, Kubo T, Yamanaka F, Tsuchihashi-Makaya M, et al
    Current state of knowledge and information sharing among home healthcare professionals involved in heart failure management.
    J Cardiol. 2022 Dec 13:S0914-5087(22)00312-4. doi: 10.1016/j.jjcc.2022.
    PubMed     Abstract available
    
    
    
36. CHIBA Y, Iwano H, Aoyagi H, Tamaki Y, et al
    Associations of right ventricular pulsatile load and cardiac power output to clinical outcomes in heart failure: Difference from systemic circulation.
    J Cardiol. 2022 Dec 8:S0914-5087(22)00311-2. doi: 10.1016/j.jjcc.2022.
    PubMed     Abstract available
    
    
    
37. OHTE N, Tanaka A, Kitada S, Yamada T, et al
    Influence of left ventricular ejection fraction on the reduction in N-terminal pro-brain natriuretic peptide by canagliflozin in patients with heart failure and type 2 diabetes: a sub analysis of the CANDLE trial.
    J Cardiol. 2022 Dec 5:S0914-5087(22)00295-7. doi: 10.1016/j.jjcc.2022.
    PubMed     Abstract available
    
    
    
38. NAMBA T, Masaki N, Hitomi Y, Ishinoda Y, et al
    Association of serum nitric oxide metabolite level with mortality in patients undergoing coronary angiography.
    J Cardiol. 2022;80:578-584.
    PubMed     Abstract available
    
    
    
39. TSUDA E, Ito Y, Kato Y, Sakaguchi H, et al
    Thirty-year outcome in children with hypertrophic cardiomyopathy based on the type.
    J Cardiol. 2022;80:557-562.
    PubMed     Abstract available
    
    
    November 2022
40. KIDA K, Miyajima I, Suzuki N, Greenberg BH, et al
    Nutritional Management of Heart Failure.
    J Cardiol. 2022 Nov 9. pii: S0914-5087(22)00272.
    PubMed     Abstract available
    
    
    
41. ZHANG T, Gao Z, Chen K
    Exosomal microRNAs: potential targets for the prevention and treatment of diabetic cardiomyopathy.
    J Cardiol. 2022;80:423-431.
    PubMed     Abstract available
    
    
    October 2022
42. LEIVA O, Jenkins A, Rosovsky RP, Leaf RK, et al
    Predictors of increased risk of adverse cardiovascular outcomes among patients with myeloproliferative neoplasms and atrial fibrillation.
    J Cardiol. 2022 Oct 29. pii: S0914-5087(22)00269.
    PubMed     Abstract available
    
    
    
43. IMAMURA T
    Clinical implication of difficulty initiating sleep in patients with heart failure.
    J Cardiol. 2022 Oct 15. pii: S0914-5087(22)00257.
    PubMed    
    
    
    
44. HASHIMOTO S, Kitakata H, Kohsaka S, Fujisawa D, et al
    Confidence in self-care after heart failure hospitalization.
    J Cardiol. 2022 Oct 11. pii: S0914-5087(22)00254.
    PubMed     Abstract available
    
    
    September 2022
45. NODA T, Kamiya K, Hamazaki N, Nozaki K, et al
    Prognostic impact of the coexistence of hepato-renal dysfunction and frailty in patients with heart failure.
    J Cardiol. 2022 Sep 24. pii: S0914-5087(22)00223.
    PubMed     Abstract available
    
    
    
46. ISHIZAKA S, Iwano H, Tsujinaga S, Murayama M, et al
    Determinants of exercise capacity in patients with heart failure without left ventricular hypertrophy.
    J Cardiol. 2022 Sep 16. pii: S0914-5087(22)00227.
    PubMed     Abstract available
    
    
    
47. MAEKAWA Y, Takamisawa I, Takano H, Takayama M, et al
    Percutaneous transluminal septal myocardial ablation: past, present, and future.
    J Cardiol. 2022;80:211-217.
    PubMed     Abstract available
    
    
    August 2022
48. KOIZUMI T, Kamada R, Watanabe M, Yokoshiki H, et al
    Predictors of cardiovascular mortality after an electrical storm in patients with structural heart disease.
    J Cardiol. 2022;80:167-171.
    PubMed     Abstract available
    
    
    
49. HATANO M, Jimba T, Fujiwara T, Tsuji M, et al
    Late-onset right ventricular failure after continuous-flow left ventricular assist device implantation: case presentation and review of the literature.
    J Cardiol. 2022;80:110-115.
    PubMed     Abstract available
    
    
    
50. ISHIDO M
    Current status and challenges of Pediatric heart transplantation in Japan.
    J Cardiol. 2022;80:145-148.
    PubMed     Abstract available
    
    
    June 2022
51. KARIM A, Muhammad T, Shah I, Khan J, et al
    A multistrain probiotic reduces sarcopenia by modulating Wnt signaling biomarkers in patients with chronic heart failure.
    J Cardiol. 2022 Jun 21. pii: S0914-5087(22)00152.
    PubMed     Abstract available
    
    
    
52. AMISAKI R, Kato M, Fujiyama M, Matsuda E, et al
    Difficulty initiating sleep in patients with heart failure: Impact of left atrial pressure.
    J Cardiol. 2022 Jun 17. pii: S0914-5087(22)00136.
    PubMed     Abstract available
    
    
    
53. YOKOYAMA Y, Kataoka N, Nakai M, Matsuo A, et al
    A new biomarker of cardiac resynchronization therapy response: cGMP to mature BNP ratio.
    J Cardiol. 2022;79:727-733.
    PubMed     Abstract available
    
    
    
54. NODA T, Lu X, Ishiguro Y, Ikuemonisan J, et al
    Cost-effective analysis of automated programming optimization in cardiac resynchronization therapy: Holistic Markov modelling.
    J Cardiol. 2022;79:734-739.
    PubMed     Abstract available
    
    
    
55. KIUCHI S, Ikeda T
    Management of hypertension associated with cardiovascular failure.
    J Cardiol. 2022;79:698-702.
    PubMed     Abstract available
    
    
    April 2022
56. AMIOKA N, Takaishi A, Nakamura K, Endo T, et al
    Innovative clinical pathway shortened the length of hospital stay and prevented readmission in patients with acute decompensated heart failure.
    J Cardiol. 2022 Apr 12. pii: S0914-5087(22)00074.
    PubMed     Abstract available
    
    
    March 2022
57. IWANO H, Utsunomiya H, Shibayama K, Tanaka H, et al
    Results of PRospect trial to Elucidate the utility of EchocarDiography-based Cardiac ouTput in acute heart failure (PREDICT).
    J Cardiol. 2022 Mar 17. pii: S0914-5087(22)00055.
    PubMed     Abstract available
    
    
    
58. NAKAI T, Ikeya Y, Kogawa R, Okumura Y, et al
    Cardiac resynchronization therapy: Current status and near-future prospects.
    J Cardiol. 2022;79:352-357.
    PubMed     Abstract available
    
    
    
59. OKI T, Ishii S, Takigami Y, Eda Y, et al
    Re-worsening left ventricular ejection fraction after response to cardiac resynchronization therapy.
    J Cardiol. 2022;79:358-364.
    PubMed     Abstract available
    
    
    February 2022
60. YOSHIKAWA T
    New paradigm shift in the pharmacotherapy for heart failure-where are we now and where are we heading?
    J Cardiol. 2022 Feb 25. pii: S0914-5087(22)00031.
    PubMed     Abstract available
    
    
    
61. SATO Y, Yoshihisa A, Takeishi R, Ohara H, et al
    B-type natriuretic peptide is associated with the occurrence of bleeding events in heart failure patients with a history of coronary artery disease.
    J Cardiol. 2022 Feb 22. pii: S0914-5087(22)00026.
    PubMed     Abstract available
    
    
    
62. KIDA K, Nabeta T, Ishida M, Shiono T, et al
    D-dimer levels in patients with nonvalvular atrial fibrillation and acute heart failure treated with edoxaban.
    J Cardiol. 2022 Feb 8. pii: S0914-5087(22)00015.
    PubMed     Abstract available
    
    
    January 2022
63. MIYANAGA S, Komukai K, Kubota T, Shirasaki K, et al
    Cancer and malnutrition were independently associated with a poor prognosis in patients with heart failure.
    J Cardiol. 2022;79:15-20.
    PubMed     Abstract available
    
    
    
64. WANG S, Jiang C, Zhao L, Sun S, et al
    Metabolic maturation during postnatal right ventricular development switches to heart-contraction regulation due to volume overload.
    J Cardiol. 2022;79:110-120.
    PubMed     Abstract available
    
    
    
65. BRONS M, Rutten FH, Zuithoff NPA, Oerlemans MIFJ, et al
    Disease management with home telemonitoring aimed at substitution of usual care in the Netherlands: Post-hoc analyses of the e-Vita HF study.
    J Cardiol. 2022;79:1-5.
    PubMed     Abstract available
    
    
    December 2021
66. YAKU H, Kaneda K, Kitamura J, Kato T, et al
    Kampo medicine for the holistic approach to older adults with heart failure.
    J Cardiol. 2021 Dec 30. pii: S0914-5087(21)00366.
    PubMed     Abstract available
    
    
    
67. KAKUTANI N, Yokota T, Fukushima A, Obata Y, et al
    Impact of citrus fruit intake on the mental health of patients with chronic heart failure.
    J Cardiol. 2021 Dec 23. pii: S0914-5087(21)00359.
    PubMed     Abstract available
    
    
    
68. SHINOMIYA H, Koyama S, Tanada Y, Takahashi N, et al
    Corrigendum to "Left ventricular end-diastolic pressure and ejection fraction correlate independently with high-sensitivity cardiac troponin-T concentrations in stable heart failure" 65 (2015) 526-530 6.
    J Cardiol. 2021 Dec 22. pii: S0914-5087(21)00317.
    PubMed    
    
    
    
69. FUKATA M, Yamasaki H, Sai E, Ogawa K, et al
    Impact of adaptive cardiac resynchronization therapy in patients with systolic heart failure: Beyond QRS duration and morphology.
    J Cardiol. 2021 Dec 19. pii: S0914-5087(21)00315.
    PubMed     Abstract available
    
    
    
70. SAITO C, Jujo K, Kametani M, Arai K, et al
    Prognostic impact of right ventricular function affected by pulmonary hypertension in hospitalized heart failure patients.
    J Cardiol. 2021 Dec 18. pii: S0914-5087(21)00279.
    PubMed     Abstract available
    
    
    
71. SAKU K, Yokota S, Nishikawa T, Kinugawa K, et al
    Interventional heart failure therapy: A new concept fighting against heart failure.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00339.
    PubMed     Abstract available
    
    
    
72. ODAJIMA S, Tanaka H, Fujimoto W, Kuroda K, et al
    Efficacy of Renin-angiotensin-aldosterone-system inhibitors for heart failure with preserved ejection fraction and left ventricular hypertrophy -from the KUNIUMI Registry Acute Cohort.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00357.
    PubMed     Abstract available
    
    
    
73. MINATOGUCHI S
    Heart failure and its treatment from the perspective of sympathetic nerve activity.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00337.
    PubMed     Abstract available
    
    
    
74. YAMAMOTO M, Ishizu T, Seo Y, Nakagawa D, et al
    Pathophysiological role of right ventricular function and interventricular functional mismatch in the development of pulmonary edema in acute heart failure.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00342.
    PubMed     Abstract available
    
    
    
75. NISHIDA H, Ota T, Onsager D, Grinstein J, et al
    Ten-year, single center experience of ambulatory axillary intra-aortic balloon pump support for heart failure.
    J Cardiol. 2021 Dec 8. pii: S0914-5087(21)00320.
    PubMed     Abstract available
    
    
    
76. OISHI H, Okumura T, Ohashi K, Kimura Y, et al
    Prognostic impact of transcardiac gradient of follistatin-like 1 reflecting hemodynamics in patients with dilated cardiomyopathy.
    J Cardiol. 2021;78:524-532.
    PubMed     Abstract available
    
    
    November 2021
77. HARADA T, Kagami K, Kato T, Obokata M, et al
    Echocardiography in the diagnostic evaluation and phenotyping of heart failure with preserved ejection fraction.
    J Cardiol. 2021 Nov 29. pii: S0914-5087(21)00313.
    PubMed     Abstract available
    
    
    
78. YAMASHITA M, Kamiya K, Hamazaki N, Nozaki K, et al
    Work status before admission relates to prognosis in older patients with heart failure partly through social frailty.
    J Cardiol. 2021 Nov 21. pii: S0914-5087(21)00307.
    PubMed     Abstract available
    
    
    
79. NAKAO Y, Kawakami H, Saito M, Inoue K, et al
    Cost-Effectiveness of long-term tolvaptan administration for chronic heart failure treatment in Japan.
    J Cardiol. 2021 Nov 16. pii: S0914-5087(21)00287.
    PubMed     Abstract available
    
    
    
80. TSAI YL, Chou RH, Lu YW, Chang CC, et al
    Associations between galectin-1, left ventricular diastolic dysfunction, and heart failure with preserved ejection fraction.
    J Cardiol. 2021 Nov 10. pii: S0914-5087(21)00258.
    PubMed     Abstract available
    
    
    October 2021
81. OKADA M, Inoue K
    Catheter ablation of atrial fibrillation with left ventricular systolic dysfunction: Potential approach to the cause of heart failure-authors' reply.
    J Cardiol. 2021;78:347-348.
    PubMed    
    
    
    September 2021
82. IWAHASHI N, Kirigaya J, Abe T, Horii M, et al
    Clinical usefulness of left ventricular outflow tract velocity time integral for heart failure with reduced ejection fraction with rapid atrial fibrillation during landiolol treatment.
    J Cardiol. 2021 Sep 23. pii: S0914-5087(21)00242.
    PubMed     Abstract available
    
    
    August 2021
83. KONISHI M, Akiyama E, Shibata A, Kida K, et al
    Moderate potassium lowering effect of exogenous atrial natriuretic peptide in patients with acute heart failure.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00197.
    PubMed     Abstract available
    
    
    
84. KANAI M, Yagishita D, Shoda M, Ejima K, et al
    Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00195.
    PubMed     Abstract available
    
    
    June 2021
85. YAMADA T, Haruki S, Minami Y, Numata M, et al
    The C-reactive protein to prealbumin ratio on admission and its relationship with outcome in patients hospitalized for acute heart failure.
    J Cardiol. 2021 Jun 10. pii: S0914-5087(21)00131.
    PubMed     Abstract available
    
    
    
86. YANAGIHARA K, Kinugasa Y, Kunimi T, Kaneko S, et al
    Child ego state and self-care behavior change in heart failure patients.
    J Cardiol. 2021 Jun 2. pii: S0914-5087(21)00128.
    PubMed     Abstract available
    
    
    
87. NISHIKIMI T, Nakagawa Y
    Potential pitfalls when interpreting plasma BNP levels in heart failure practice.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00114.
    PubMed     Abstract available
    
    
    
88. TOMII D, Horiuchi Y, Gonda Y, Yoshiura D, et al
    The role of the renal resistance index in patients with heart failure with reduced or preserved ejection fraction.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00130.
    PubMed     Abstract available
    
    
    May 2021
89. TSAI YN, Cheng WH, Chang YT, Hsiao YW, et al
    Mechanism of angiotensin receptor-neprilysin inhibitor in suppression of ventricular arrhythmia.
    J Cardiol. 2021 May 28. pii: S0914-5087(21)00108.
    PubMed     Abstract available
    
    
    
90. HITOMI Y, Nagatomo Y, Yukino M, Yumita Y, et al
    Characterization of tolvaptan response and its impact on the outcome for patients with heart failure.
    J Cardiol. 2021 May 23. pii: S0914-5087(21)00111.
    PubMed     Abstract available
    
    
    April 2021
91. MARUYAMA M, Yasuoka R, Nagano T, Nakazawa G, et al
    Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study.
    J Cardiol. 2021 Apr 30. pii: S0914-5087(21)00091.
    PubMed     Abstract available
    
    
    
92. NAKAMURA T, Tsujita K
    Current trends and future perspectives for heart failure treatment leveraging cGMP modifiers and the practical effector PKG.
    J Cardiol. 2021 Apr 1. pii: S0914-5087(21)00059.
    PubMed     Abstract available
    
    
    
93. NAKAJIMA DOI S, Seguchi O, Yamamoto M, Fujita T, et al
    Impact of bridge-to-bridge strategies from paracorporeal to implantable left ventricular assist devices on the pre-heart transplant outcome: A single-center analysis of 134 cases.
    J Cardiol. 2021;77:408-416.
    PubMed     Abstract available
    
    
    March 2021
94. YOKOYAMA H, Shishido K, Tobita K, Moriyama N, et al
    Impact of age on mid-term clinical outcomes and left ventricular reverse remodeling after cardiac resynchronization therapy.
    J Cardiol. 2021;77:254-262.
    PubMed     Abstract available
    
    
    
95. DAYANAND S, Martinez JM, Figueredo VM, Gupta S, et al
    Mechanical Circulatory Support in Women.
    J Cardiol. 2021;77:209-216.
    PubMed     Abstract available
    
    
    February 2021
96. MAEMURA K, Ikeda Y, Oki T, Yazaki M, et al
    Clinical significance of ischemia-like electrocardiographic finding during heart failure treatment on left ventricular recovery in patients with non-ischemic dilated cardiomyopathy.
    J Cardiol. 2021 Feb 19. pii: S0914-5087(21)00037.
    PubMed     Abstract available
    
    
    
97. KIKUCHI A, Taniguchi T, Nakamoto K, Sera F, et al
    Feasibility of home-based cardiac rehabilitation using an integrated telerehabilitation platform in elderly patients with heart failure: A pilot study.
    J Cardiol. 2021 Feb 10. pii: S0914-5087(21)00023.
    PubMed     Abstract available
    
    
    
98. SOEDA T, Okura H, Saito Y, Nakao K, et al
    Clinical characteristics and in-hospital outcomes in patients aged 80 years or over with cardiac troponin-positive acute myocardial infarction -J-MINUET study.
    J Cardiol. 2021;77:139-146.
    PubMed     Abstract available
    
    
    
99. NAITO Y, Masuyama T, Ishihara M
    Iron and cardiovascular diseases.
    J Cardiol. 2021;77:160-165.
    PubMed     Abstract available
    
    
    January 2021
100. FUJIMOTO W, Konishi A, Iwasaki M, Toh R, et al
     Precipitating factors and clinical impact of early rehospitalization for heart failure in patients with heart failure in Awaji Island, Japan.
     J Cardiol. 2021 Jan 5. pii: S0914-5087(20)30418.
     PubMed     Abstract available
     
     
     
101. SHIINA Y, Nagao M, Shimomiya Y, Inai K, et al
     Secondary sarcopenia assessed by computed tomography can predict hospitalization for heart failure in adults with Fontan circulation.
     J Cardiol. 2021;77:10-16.
     PubMed     Abstract available
     
     
     
102. KANAMORI H, Naruse G, Yoshida A, Minatoguchi S, et al
     Morphological characteristics in diabetic cardiomyopathy associated with autophagy.
     J Cardiol. 2021;77:30-40.
     PubMed     Abstract available
     
     
     December 2020
103. TANAKA H, Yamauchi Y, Imanishi J, Hatani Y, et al
     Effect of ivabradine on left ventricular diastolic function of patients with heart failure with preserved ejection fraction -IVA-PEF study.
     J Cardiol. 2020 Dec 31. pii: S0914-5087(20)30417.
     PubMed     Abstract available
     
     
     
104. NATANZON SS, Mazin I
     Author's reply: The outcome of acute decompensated heart failure stratified by the Norton scale on admission.
     J Cardiol. 2020 Dec 4. pii: S0914-5087(20)30385.
     PubMed    
     
     
     
105. IZUMIDA T, Imamura T
     The outcome of acute decompensated heart failure stratified by the Norton scale on admission.
     J Cardiol. 2020 Dec 3. pii: S0914-5087(20)30386.
     PubMed    
     
     
     
106. IZUMIDA T, Imamura T
     Sarcopenia in patients with cardiovascular disease.
     J Cardiol. 2020;76:636.
     PubMed    
     
     
     November 2020
107. KURODA S, Mizukami A, Hiroki J, Shimizu Y, et al
     Clinical impact of serial change in brain natriuretic peptide before and after catheter ablation in patients with atrial fibrillation and heart failure.
     J Cardiol. 2020 Nov 25. pii: S0914-5087(20)30374.
     PubMed     Abstract available
     
     
     
108. CHANG WT, Lin CH, Hong CS, Liao CT, et al
     The predictive value of global longitudinal strain in patients with heart failure mid-range ejection fraction.
     J Cardiol. 2020 Nov 21. pii: S0914-5087(20)30359.
     PubMed     Abstract available
     
     
     
109. HATA R, Kato T, Yaku H, Morimoto T, et al
     Implantable Cardioverter Defibrillator Therapy in Patients with Acute Decompensated Heart Failure with Reduced Ejection Fraction: An Observation from the KCHF Registry.
     J Cardiol. 2020 Nov 12. pii: S0914-5087(20)30339.
     PubMed     Abstract available
     
     
     October 2020
110. MIRO O, Lopez-Diez MP, Rossello X, Gil V, et al
     Analysis of standards of quality for outcomes in acute heart failure patients directly discharged home from emergency departments and their relationship with the emergency department direct discharge rate.
     J Cardiol. 2020 Oct 11. pii: S0914-5087(20)30307.
     PubMed     Abstract available
     
     
     September 2020
111. KOBAYASHI S, Yoshiga Y, Yano M
     Author's reply: The RyR2 - Targeting therapy against lethal arrhythmia.
     J Cardiol. 2020;76:323-324.
     PubMed    
     
     
     May 2020
112. SATO K, Takahashi J, Hao K, Miyata S, et al
     Temporal trends in the prevalence and outcomes of geriatric patients with acute myocardial infarction in Japan-A report from the Miyagi AMI Registry Study.
     J Cardiol. 2020;75:465-472.
     PubMed     Abstract available
     
     
     April 2020
113. KODZISZEWSKA K, Sochanowicz B, Smigielski W, Kruszewski M, et al
     Grey areas and open questions in neprilysin inhibition.
     J Cardiol. 2020;75:462-463.
     PubMed    
     
     
     
114. CHANG HY, Yin WH
     Response to "Grey Areas and Open Questions in Neprilysin Inhibition".
     J Cardiol. 2020;75:463-464.
     PubMed    
     
     
     
115. LIANG Y, Wang J, Yu Z, Zhang M, et al
     Comparison between cardiac resynchronization therapy with and without defibrillator on long-term mortality: A propensity score matched analysis.
     J Cardiol. 2020;75:432-438.
     PubMed     Abstract available
     
     
     March 2020
116. CHANG HY, Chen KC, Fong MC, Feng AN, et al
     Recovery of left ventricular dysfunction after sacubitril/valsartan: predictors and management.
     J Cardiol. 2020;75:233-241.
     PubMed     Abstract available
     
     
     September 2019
117. HAYASHI H, Abe Y, Morita Y, Yamaji Y, et al
     Prognostic significance of moderate primary mitral regurgitation and concomitant paroxysmal atrial fibrillation.
     J Cardiol. 2019 Sep 12. pii: S0914-5087(19)30276.
     PubMed     Abstract available
     
     
     
118. YAMASAKI H, Sekiguchi Y, Gosho M, Nogami A, et al
     Design and results of aCRT MID-Q study: Adoption of adaptive CRT in patients with normal AV conduction and moderately wide left bundle branch block.
     J Cardiol. 2019 Sep 3. pii: S0914-5087(19)30262.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.